30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

Onkos Surgical to Distribute OsteoCrete Bone Void Filler -

Onkos Surgical will market Bone Solutions' OsteoCrete® magnesium-based bone void filler under the GenVie™ brand through a private label agreement, for use in certain tumor and complex revision cases. FDA has cleared OsteoCrete for use in bone-related surgical procedures ranging from complex injuries to all musculoskeletal extremities trauma cases. BSI is focused on further development of bioresorbable implants and will continue to explore its applications. Earlier this month, WishBone Medical entered into a private label agreement with BSI for worldwide rights to distribute OsteoCrete for use in pediatric procedures. (Bone Solutions Inc., 8/28/19)